Clinical Trial Update: A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating GRC 17536 for Painful Diabetic Neuropathy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy

Drugs mentioned

• GRC 17536 (GRC-17536)

Snippet

Sponsor: Glenmark Pharmaceuticals Ltd. India | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: WITHDRAWN